Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Tempest Therapeutics (TPST)
NASDAQ:TPST
RESEARCH TOOLSreports
Tempest Therapeutics (TPST) Stock Price & Analysis
902 Followers
TPST Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.17 - $9.77
Previous Close$2.22
Volume423.23K
Average Volume (3M)989.22K
Market Cap
$49.54M
Enterprise Value$37.39M
Total Cash (Recent Filing)$32.30M
Total Debt (Recent Filing)$20.37M
Price to Earnings (P/E)―
Beta2.24
Next Earnings
Aug 12, 2024EPS Estimate
-$0.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.72
Shares Outstanding22,217,265
10 Day Avg. Volume3,703,893
30 Day Avg. Volume989,218
Standard Deviation1.64
R-Squared0.00318
Alpha0.15
Financial Highlights & Ratios
Price to Book (P/B)2.19
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.60
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-1.33
Forecast
1Y Price Target
$30.00Price Target Upside1251.35% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Tempest Therapeutics News
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
TPST FAQ
What was Tempest Therapeutics’s price range in the past 12 months?
Tempest Therapeutics lowest stock price was $0.17 and its highest was $9.77 in the past 12 months.
What is Tempest Therapeutics’s market cap?
Currently, no data Available
When is Tempest Therapeutics’s upcoming earnings report date?
Tempest Therapeutics’s upcoming earnings report date is Aug 12, 2024 which is in 21 days.
How were Tempest Therapeutics’s earnings last quarter?
Tempest Therapeutics released its earnings results on May 09, 2024. The company reported -$0.36 earnings per share for the quarter, beating the consensus estimate of -$0.403 by $0.043.
Is Tempest Therapeutics overvalued?
According to Wall Street analysts Tempest Therapeutics’s price is currently Undervalued.
Does Tempest Therapeutics pay dividends?
Tempest Therapeutics does not currently pay dividends.
What is Tempest Therapeutics’s EPS estimate?
Tempest Therapeutics’s EPS estimate is -$0.4.
How many shares outstanding does Tempest Therapeutics have?
Tempest Therapeutics has 22,217,264 shares outstanding.
What happened to Tempest Therapeutics’s price movement after its last earnings report?
Tempest Therapeutics reported an EPS of -$0.36 in its last earnings report, beating expectations of -$0.403. Following the earnings report the stock price went down -6.34%.
Which hedge fund is a major shareholder of Tempest Therapeutics?
Currently, no hedge funds are holding shares in TPST
---
Tempest Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$30.00 (1251.35% Upside)
$30.00 (1251.35% Upside)
Blogger Sentiment
Bullish
TPST Sentiment 90%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Negative
Last 7 Days ▼ 3.0%
Last 30 Days ▼ 3.0%
Last 30 Days ▼ 3.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
108.41%
12-Months-Change
Fundamentals
Return on Equity
-188.37%
Trailing 12-Months
Asset Growth
18.88%
Trailing 12-Months
Company Description
Tempest Therapeutics
Tempest Therapeutics is a clinical-stage biotechnology company focused on developing small-molecule therapeutics to treat cancer.
---
TPST Stock 12 Month Forecast
Average Price Target
$30.00
▲(1251.35% Upside)
Technical Analysis
Best Analysts Covering TPST
1 Year
1 Year Success Rate
6/11 ratings generated profit
1 Year Average Return
+101.02%
reiterated a buy rating last month
Copying Joseph Pantginis's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of +101.02% per trade.
---